Skip to content
No picture yet

Sohonos 5 mg – DIN 02524651

Sohonos is Palovarotene 5 mg (capsule), sold in Canada. It is used for heterotopic ossification. It is supplied by Ipsen Biopharmaceuticals Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Palovarotene 5 mg

Brand
Sohonos
Strength
5 mg
Used for
Heterotopic ossification
Form
Capsule
Manufacturer
Ipsen Biopharmaceuticals Canada Inc
Drug class
Retinoid
Sold in
Canada
DIN
02524651

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Palovarotene pills and guides

What is Palovarotene used for?

Palovarotene is used for heterotopic ossification.

Medicine type
Retinoid
Official uses from the US prescribing label

SOHONOS is indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP).

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02524651.
  • It names Sohonos, Palovarotene 5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Sohonos by Ipsen Biopharmaceuticals Canada Inc.

In Canada: prescription only.

Ingredients

Active: Palovarotene

Other Palovarotene pills